Sakar Healthcare Limited (NSE:SAKAR)
330.00
+1.45 (0.44%)
Sep 10, 2025, 11:29 AM IST
Sakar Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 1,892 | 1,776 | 1,534 | 1,334 | 1,282 | 947.39 | Upgrade |
Other Revenue | - | - | 8.16 | 8.33 | 8.91 | 5.72 | Upgrade |
1,892 | 1,776 | 1,542 | 1,342 | 1,291 | 953.12 | Upgrade | |
Revenue Growth (YoY) | 21.65% | 15.19% | 14.89% | 3.93% | 35.47% | 13.58% | Upgrade |
Cost of Revenue | 891.54 | 822.63 | 842.09 | 737.45 | 748.77 | 514.6 | Upgrade |
Gross Profit | 1,000 | 953.22 | 699.59 | 604.47 | 542.41 | 438.52 | Upgrade |
Selling, General & Admin | 338.14 | 316.49 | 198.62 | 169.35 | 153.55 | 132.82 | Upgrade |
Other Operating Expenses | 145.16 | 139.9 | 106.73 | 94.1 | 85.81 | 73.86 | Upgrade |
Operating Expenses | 697.26 | 665.21 | 485.85 | 413.3 | 336.04 | 287.26 | Upgrade |
Operating Income | 302.93 | 288.01 | 213.73 | 191.17 | 206.38 | 151.26 | Upgrade |
Interest Expense | -92.8 | -85.35 | -67.45 | -54.88 | -25.88 | -23.34 | Upgrade |
Interest & Investment Income | - | - | 1.25 | 3.93 | 0.56 | 0.16 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 17.23 | 34.49 | 11.62 | 5.85 | Upgrade |
Other Non Operating Income (Expenses) | 12.47 | 13.13 | -8.71 | -4.75 | -3.22 | -1.61 | Upgrade |
EBT Excluding Unusual Items | 222.6 | 215.79 | 156.06 | 169.96 | 189.46 | 132.33 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 2.94 | - | 0.62 | - | Upgrade |
Other Unusual Items | -0.51 | -0.51 | - | -0.05 | - | - | Upgrade |
Pretax Income | 222.09 | 215.27 | 159 | 169.91 | 190.08 | 132.33 | Upgrade |
Income Tax Expense | 24.48 | 40.25 | 42.29 | 42.33 | 37.65 | 25.5 | Upgrade |
Net Income | 197.61 | 175.02 | 116.71 | 127.59 | 152.43 | 106.83 | Upgrade |
Net Income to Common | 197.61 | 175.02 | 116.71 | 127.59 | 152.43 | 106.83 | Upgrade |
Net Income Growth | 75.77% | 49.96% | -8.53% | -16.30% | 42.69% | 11.01% | Upgrade |
Shares Outstanding (Basic) | 22 | 22 | 21 | 19 | 15 | 15 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 21 | 19 | 15 | 15 | Upgrade |
Shares Change (YoY) | 2.89% | 7.26% | 10.39% | 23.33% | - | 0.77% | Upgrade |
EPS (Basic) | 8.98 | 7.97 | 5.69 | 6.86 | 10.11 | 7.09 | Upgrade |
EPS (Diluted) | 8.98 | 7.95 | 5.69 | 6.86 | 10.11 | 7.09 | Upgrade |
EPS Growth | 70.83% | 39.81% | -17.14% | -32.13% | 42.69% | 10.17% | Upgrade |
Free Cash Flow | - | 17.5 | -350.93 | -488.51 | -109.08 | -209.69 | Upgrade |
Free Cash Flow Per Share | - | 0.80 | -17.10 | -26.27 | -7.24 | -13.91 | Upgrade |
Gross Margin | 52.87% | 53.68% | 45.38% | 45.05% | 42.01% | 46.01% | Upgrade |
Operating Margin | 16.01% | 16.22% | 13.86% | 14.25% | 15.98% | 15.87% | Upgrade |
Profit Margin | 10.45% | 9.86% | 7.57% | 9.51% | 11.80% | 11.21% | Upgrade |
Free Cash Flow Margin | - | 0.98% | -22.76% | -36.40% | -8.45% | -22.00% | Upgrade |
EBITDA | 519.07 | 496.83 | 393.27 | 341.03 | 279.66 | 206.34 | Upgrade |
EBITDA Margin | 27.44% | 27.98% | 25.51% | 25.41% | 21.66% | 21.65% | Upgrade |
D&A For EBITDA | 216.14 | 208.82 | 179.54 | 149.86 | 73.28 | 55.08 | Upgrade |
EBIT | 302.93 | 288.01 | 213.73 | 191.17 | 206.38 | 151.26 | Upgrade |
EBIT Margin | 16.01% | 16.22% | 13.86% | 14.25% | 15.98% | 15.87% | Upgrade |
Effective Tax Rate | 11.02% | 18.70% | 26.60% | 24.91% | 19.81% | 19.27% | Upgrade |
Revenue as Reported | 1,904 | 1,789 | 1,565 | 1,380 | 1,304 | 959.15 | Upgrade |
Advertising Expenses | - | - | 0.07 | 0.28 | 0.22 | 0.06 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.